To the Editor—Risk factors for infectious disease severity are determined by the pathogen, host, and environment [1]. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, includes a spectrum of illness, from asymptomatic infection [2] to severe pneumonia characterized by acute respiratory injury in about 20% of patients presenting to medical care [3]. The risk factors associated with disease severity include increased age, diabetes, immunosuppression, and organ failure [3]. Recognition of risk factors for morbidity and mortality is important to determine prevention strategies as well as to target high-risk populations for potential therapeutics.

We performed a retrospective analysis of body mass index (BMI) stratified by age in COVID-19–positive symptomatic patients who presented to a large academic hospital system in New York City. Patients presenting to the emergency department (ED) with signs of respiratory distress were admitted to the hospital. Critical care was defined based on intensive care accommodation status or invasive ventilator documentation in our electronic health record. Patients who were polymerase chain reaction positive for COVID-19 during 3 March–4 April 2020 were extracted from our electronic health record system and analyzed with a χ 2 Wald test using SAS version 9.4 software (SAS Institute, Cary, North Carolina).

Of the 3615 individuals who tested positive for COVID-19, 775 (21%) had a body mass index (BMI; kg/m2) 30–34, and 595 (16% of the total cohort) had a BMI ≥ 35. A total of 1853 (51%) were patients discharged from the ED, 1331 (37%) were admitted to the hospital in acute care, and 431 (12%) were either directly admitted or transferred to the intensive care unit (ICU) during admission. During analysis, we found significant differences in admission and ICU care only in patients < 60 years of age with varying BMIs (Table 1)

Table 1.

Adult Patients Who Tested Positive for COVID-19 During 3 March–4 April 2020 (N = 3615)

BMI, kg/m2No. (%)Admission to Acute (vs Discharge From ED), OR (95% CI)P ValueNo. (%)ICU Admission (vs Discharge From ED), OR (95% CI)P Value
Age ≥ 60 y
 BMI 30–34141 (19)0.9 (.6–1.2).3957 (22)1.1 (.8–1.7).57
 BMI ≥ 3599 (14)0.9 (.6–1.3).5950 (19)1.5 (.9–2.3).10
Age < 60 y
 BMI 30–34173 (29)2.0 (1.6–2.6)< .000139 (23)1.8 (1.2–2.7).006
 BMI ≥ 35134 (22)2.2 (1.7–2.9)< .000156 (33)3.6 (2.5–5.3)< .0001
BMI, kg/m2No. (%)Admission to Acute (vs Discharge From ED), OR (95% CI)P ValueNo. (%)ICU Admission (vs Discharge From ED), OR (95% CI)P Value
Age ≥ 60 y
 BMI 30–34141 (19)0.9 (.6–1.2).3957 (22)1.1 (.8–1.7).57
 BMI ≥ 3599 (14)0.9 (.6–1.3).5950 (19)1.5 (.9–2.3).10
Age < 60 y
 BMI 30–34173 (29)2.0 (1.6–2.6)< .000139 (23)1.8 (1.2–2.7).006
 BMI ≥ 35134 (22)2.2 (1.7–2.9)< .000156 (33)3.6 (2.5–5.3)< .0001

Abbreviations: BMI, body mass index; CI, confidence interval; COVID-19, coronavirus disease 2019; ED, emergency department; ICU, intensive care unit; OR, odds ratio.

Table 1.

Adult Patients Who Tested Positive for COVID-19 During 3 March–4 April 2020 (N = 3615)

BMI, kg/m2No. (%)Admission to Acute (vs Discharge From ED), OR (95% CI)P ValueNo. (%)ICU Admission (vs Discharge From ED), OR (95% CI)P Value
Age ≥ 60 y
 BMI 30–34141 (19)0.9 (.6–1.2).3957 (22)1.1 (.8–1.7).57
 BMI ≥ 3599 (14)0.9 (.6–1.3).5950 (19)1.5 (.9–2.3).10
Age < 60 y
 BMI 30–34173 (29)2.0 (1.6–2.6)< .000139 (23)1.8 (1.2–2.7).006
 BMI ≥ 35134 (22)2.2 (1.7–2.9)< .000156 (33)3.6 (2.5–5.3)< .0001
BMI, kg/m2No. (%)Admission to Acute (vs Discharge From ED), OR (95% CI)P ValueNo. (%)ICU Admission (vs Discharge From ED), OR (95% CI)P Value
Age ≥ 60 y
 BMI 30–34141 (19)0.9 (.6–1.2).3957 (22)1.1 (.8–1.7).57
 BMI ≥ 3599 (14)0.9 (.6–1.3).5950 (19)1.5 (.9–2.3).10
Age < 60 y
 BMI 30–34173 (29)2.0 (1.6–2.6)< .000139 (23)1.8 (1.2–2.7).006
 BMI ≥ 35134 (22)2.2 (1.7–2.9)< .000156 (33)3.6 (2.5–5.3)< .0001

Abbreviations: BMI, body mass index; CI, confidence interval; COVID-19, coronavirus disease 2019; ED, emergency department; ICU, intensive care unit; OR, odds ratio.

Patients aged < 60 years with a BMI between 30 and 34 were 2.0 (95% confidence interval [CI], 1.6–2.6; P < .0001) and 1.8 (95% CI, 1.2–2.7; P = .006) times more likely to be admitted to acute and critical care, respectively, compared to individuals with a BMI < 30 (Table 1). Likewise, patients with a BMI ≥ 35 and aged < 60 years were 2.2 (95% CI, 1.7–2.9; P < .0001) and 3.6 (95% CI, 2.5–5.3; P < .0001) times more likely to be admitted to acute and critical care than patients in the same age category who had BMI < 30.

Though patients aged < 60 years are generally considered a lower-risk group of COVID-19 disease severity, based on data from our institution, obesity appears to be a previously unrecognized risk factor for hospital admission and need for critical care. This has important and practical implications, where nearly 40% of adults in the United States are obese with a BMI ≥ 30 [4]. The BMI range of individuals in this study appears representative of the nation, as 37% of the patients have a BMI ≥ 30. There is geographic variation in reported mortality, as South Korea, China, and Italy have reported case fatality rates of 0.8, 2.3, and 7.2, respectively [5] and regional risk factors such as prevalence of smoking, pollution, or aging population have been cited. Unfortunately, obesity in people < 60 years is a newly identified epidemiologic risk factor that may contribute to increased morbidity rates experienced in the United States.

Note

Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.

References

1.

Smith
KF
,
Dobson
AP
,
McKenzie
FE
,
Real
LA
,
Smith
DL
,
Wilson
ML
.
Ecological theory to enhance infectious disease control and public health policy
.
Front Ecol Environ
2005
;
3
:
29
37
.

2.

Mizumoto
K
,
Kagaya
K
,
Zarebski
A
,
Chowell
G
.
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020
.
Euro Surveill
2020
;
25
. doi:10.2807/1560-7917.ES.2020.25.10.2000180.

3.

Wu
Z
,
McGoogan
JM
.
Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention
.
JAMA
2020
. doi:10.1001/jama.2020.2648.

4.

Ogden
CL
,
Fakhouri
TH
,
Carroll
MD
, et al. 
Prevalence of obesity among adults, by household income and education—United States, 2011-2014
.
MMWR Morb Mortal Wkly Rep
2017
;
66
:
1369
73
.

5.

Onder
G
,
Rezza
G
,
Brusaferro
S
.
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
.
JAMA
2020
. doi:10.1001/jama.2020.4683.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.